These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7951528)

  • 21. Cushing's disease caused by ectopic pituitary adenoma within the pituitary stalk.
    Tal A
    South Med J; 1993 Feb; 86(2):249-50. PubMed ID: 8381988
    [No Abstract]   [Full Text] [Related]  

  • 22. Circulating adrenomedullin is increased in patients with corticotropin-dependent Cushing's syndrome due to pituitary adenoma.
    Letizia C; Di Iorio R; De Toma G; Marinoni E; Cerci S; Celi M; Subioli S; D'Erasmo E
    Metabolism; 2000 Jun; 49(6):760-3. PubMed ID: 10877203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exaggerated response of adrenocorticotropic hormone to growth hormone-releasing peptide-2 test in Cushing's disease. Case report.
    Sakihara S; Kageyama K; Matsumoto A; Ikeda H; Tsushima Y; Naraoka M; Terui K; Nigawara T; Suda T
    Neurol Med Chir (Tokyo); 2009 Aug; 49(8):365-9. PubMed ID: 19707004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess.
    Colombo P; Passini E; Re T; Faglia G; Ambrosi B
    Clin Endocrinol (Oxf); 1997 Jun; 46(6):661-8. PubMed ID: 9274696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corticotropin releasing factor (CRF): diagnostic implications.
    Müller OA; Stalla GK; Hartwimmer J; Schopohl J; von Werder K
    Acta Neurochir (Wien); 1985; 75(1-4):49-59. PubMed ID: 2986422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracavernous sinus ectopic adrenocorticotropin-secreting tumours causing therapeutic failure in transsphenoidal surgery for Cushing's disease.
    Ohnishi T; Arita N; Yoshimine T; Mori S
    Acta Neurochir (Wien); 2000; 142(8):855-64. PubMed ID: 11086823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Criteria of cure and remission in Cushing's disease: an update.
    Czepielewski MA; Rollin GA; Casagrande A; Ferreira NP
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1362-72. PubMed ID: 18209875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnosis and differential diagnosis of Cushing's syndrome].
    Santos S; Santos E; Gaztambide S; Salvador J
    Endocrinol Nutr; 2009 Feb; 56(2):71-84. PubMed ID: 19627715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pituitary tumour localization in patients with Cushing's disease by magnetic resonance imaging. Is there a place for petrosal sinus sampling?
    de Herder WW; Uitterlinden P; Pieterman H; Tanghe HL; Kwekkeboom DJ; Pols HA; Singh R; van de Berge JH; Lamberts SW
    Clin Endocrinol (Oxf); 1994 Jan; 40(1):87-92. PubMed ID: 8306486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibodies to pituitary corticotropin-producing cells: possible marker for unfavourable outcome after pituitary microsurgery for Cushing's disease.
    Scherbaum WA; Schrell U; Glück M; Fahlbusch R; Pfeiffer EF
    Lancet; 1987 Jun; 1(8547):1394-8. PubMed ID: 2884495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pituitary microadenoma of Cushing's disease. Course following transsphenoidal excision. Four cases (author's transl)].
    Guibout M; Jaquet P; Grisoli F; Louvet JP; Combes R; Angeletti S; Mouly A
    Nouv Presse Med; 1979 Oct; 8(37):2959-63. PubMed ID: 503829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin, Cushing's disease, and depression.
    Sonino N; Fava GA
    Psychother Psychosom; 1996; 65(2):63-5. PubMed ID: 8711083
    [No Abstract]   [Full Text] [Related]  

  • 33. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease.
    Isidori AM; Kaltsas GA; Korbonits M; Pyle M; Gueorguiev M; Meinhardt A; Metz C; Petrovsky N; Popovic V; Bucala R; Grossman AB
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1834-40. PubMed ID: 11932327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
    Yap LB; Turner HE; Adams CB; Wass JA
    Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Petrosal sinus sampling for diagnosis of Cushing's disease: evidence of false negative results.
    López J; Barceló B; Lucas T; Salame F; Alameda C; Boronat M; Salto L; Estrada J
    Clin Endocrinol (Oxf); 1996 Aug; 45(2):147-56. PubMed ID: 8881446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infrasellar pituitary gangliocytoma causing Cushing's syndrome.
    Domingue ME; Marbaix E; Do Rego JL; Col V; Raftopoulos C; Duprez T; Vaudry H; Maiter D
    Pituitary; 2015 Oct; 18(5):738-44. PubMed ID: 25183169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paediatric Cushing's disease: long-term outcome and predictors of recurrence.
    Savage MO; Ferrigno R
    Front Endocrinol (Lausanne); 2024; 15():1345174. PubMed ID: 38318299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cushing's disease due to pituitary gland tumor and paradoxical response to dexamethasone].
    Peillon F; Boyet F; Malinsky M
    Nouv Presse Med; 1974 Dec; 3(45):2727-8. PubMed ID: 4376599
    [No Abstract]   [Full Text] [Related]  

  • 40. [Differential diagnosis and medical treatment in Cushing's disease].
    Beckers A; Valdes-Socin H; Betea D; Stevenaert A
    Neurochirurgie; 2002 May; 48(2-3 Pt 2):163-72. PubMed ID: 12058123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.